Skip to main content
. 2022 Nov 30;9(12):ofac644. doi: 10.1093/ofid/ofac644

Table 4.

Willingness to Enroll Patients in Future Randomized Clinical Trials on Treatment of Acute Herpes Simplex Virus Type 2 Meningitis

Randomized Controlled Trial Willingness to Include Patients in Trial
no./No. (%)
Acyclovir or valacyclovir vs placebo 143/183 (78)
Acyclovir vs valacyclovir 159/183 (87)
Duration of therapy 167/183 (91)
Adjunctive dexamethasone 128/183 (70)